RSS
RSS feeds are a way to get ongoing headlines and summaries from Elsevier Business Intelligence based on your interests and formatted for your feed reader of choice.
Subscribe to our most popular feeds or create your own. More Info & Feed Readers »
Publications
Biopharma
- “The Pink Sheet”
Expert analysis of biopharma regulatory, legislative, legal and business developments.
In-depth analysis of the key developments shaping the biopharma industry.- “The Gold Sheet”
Insightful analysis on U.S. and international pharmaceutical manufacturing QA/QC.
- PharmAsia News
Highly specialized industry insight on Asian marketplace plus around-the-clock news.
- Pharmaceutical Approvals Monthly
In-depth coverage of U.S. drug approvals.
- IN VIVO
The premier strategic business resource for the biopharma, medtech, and diagnostics industries.
- Start-Up
In-depth profiles of leading-edge companies and technology.
- The RPM Report
Actionable insight on regulation, policy, FDA and CMS.
- Health News Daily
Health care issues including prescription and non-prescription pharmaceuticals and federal health policy.
Device
- “The Gray Sheet”
In-depth specialized coverage of the medical device, diagnostic, instrumentation industries.
- IN VIVO
The premier strategic business resource for the biopharma, medtech, and diagnostics industries.
- Start-Up
In-depth profiles of leading-edge companies and technology.
- “The Silver Sheet”
In-depth news/analysis of FDA's interpretation/enforcement of the Quality System Regulation.
- Medtech Insight
Quality content on medical technologies impacting the spectrum of markets.
- Health News Daily
Health care issues including prescription and non-prescription pharmaceuticals and federal health policy.
Consumer
- “The Rose Sheet”
Regulatory, legislative, scientific, financial, marketing, legal news in the skin care industry.
- “The Tan Sheet”
In-depth news/analysis of the nonprescription pharma and dietary supplement industries.
- Health News Daily
Health care issues including prescription and non-prescription pharmaceuticals and federal health policy.
Deals
Deals RSS Feeds
Elsevier Business Intelligence's Strategic Transactions delivers the most comprehensive deals data in the industry, including alliances, financings, and M&As across biopharma, devices, diagnostics and tech transfers.
Biopharma
Device
In Vitro Diagnostics
E-Letters & Blogs
E-Letters & Blogs RSS Feeds
- BioPharma Today
Around-the-clock news and analysis of regulatory, legal, and financial developments.
- The IN VIVO Blog
Daily commentary on biopharma business development, R&D, financing, marketing, and policy.
- Medical Devices Today
The leading source for in-depth news & analysis of the medtech and diagnostics industries.
- EuroPharma Today
Analysis of regulatory, legal and financial developments impacting the biopharma industry in Europe.
- Over The Counter Today
In-depth news/analysis of the OTC drug, dietary supplement, and personal care industries.
Hot Topics
Hot Topics RSS Feeds
- Advisory Committees
The latest news on FDA Advisory Committees.
- Dealmaking
Biopharma and device dealmaking, including alliances, acquisitions, and financing.
- Emerging Markets
Drug and device development, marketing, and dealmaking in emerging markets, including China, India, and Eastern Europe.
- Health Care Reform
U.S. federal and regional efforts to reform health care and their impact on the biopharma and device industries.
- Comparative Effectiveness
Initiatives to compare competing medical treatments and their impact on the biopharma and device industries.
- Reimbursement
Planning for reimbursement as a key factor at all stages of drug and device development.
- REMS
How FDA's authority to require risk evaluation and mitigation strategies is changing drug development and commercialization.
- Biosimilars
Challenges and opportunities in making generic versions of large molecule drugs.